Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pioglitazone influence of triglyceride accumulation in the myocardium in diabetes

Next Previous
Trial Profile

Pioglitazone influence of triglyceride accumulation in the myocardium in diabetes

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 19 Nov 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pioglitazone (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms PIRAMID

    • Most Recent Events

    • 16 Sep 2011 Results of an analysis that focused on plasma omentin levels presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
    • 29 Jun 2010 Effects of pioglitazone on plasma cholesteryl ester transfer protein (CETP) mass have been presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
    • 01 Jan 2010 Effects on pericardial fat volume have been published in the Journal of Clinical Endocrinology and Metabolism.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top